ICascara Sagrada

-Delile

• Kungenzeka kusebenze ...
• Kungenzeka kungasebenzi ku ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

ICascara sagrada isihlahla. Amagxolo omisiwe asetshenziselwa ukwenza umuthi.

ICascara sagrada yayijwayele ukuvunywa yi-U.S. Food and Drug Administration (FDA) njengesidakamizwa esingaphezulu kwe-the-counter (OTC) sokuqunjelwa. Kodwa-ke, eminyakeni edlule, ukukhathazeka kwaphakanyiswa ngokuphepha nokusebenza kwe-cascara sagrada. I-FDA inikeze abakhiqizi ithuba lokuhambisa ulwazi lokuphepha nokusebenza ukuze baphendule lezi zinto ezikhathazayo. Kepha izinkampani zinqume ukuthi izindleko zokwenza izifundo zokuphepha nokusebenza kahle kungenzeka zibe ngaphezu kwenzuzo abangayilindela ekuthengisweni kwe-cascara sagrada. Ngakho-ke abahambisani nesicelo. Ngenxa yalokho, abakhiqizi be-FDA bazise abakhiqizi ukuthi basuse noma baguqule kabusha yonke imikhiqizo ye-laxative ye-OTC equkethe i-cascara sagrada evela emakethe yase-U.S. NgoNovemba 5, 2002. Namuhla, ungathenga i-cascara sagrada "njengesengezo sokudla", kodwa hhayi njengesidakamizwa. "Izithako zokudla" akudingeki zihlangabezane namazinga i-FDA esebenza kuwo i-OTC noma imishanguzo kadokotela.

ICascara sagrada ivame ukusetshenziswa ngomlomo njenge-laxative yokuqunjelwa.

Ekudleni naseziphuzweni, kwesinye isikhathi kukhishwa i-cascara sagrada njenge-ejenti yokunambitha.

Ekhiqizeni, i-cascara sagrada isetshenziselwa ukucubungula ezinye izikrini zelanga.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze UCASCARA SAGRADA zimi kanje:

Kungenzeka kusebenze ...

• Ukuqunjelwa. ICascara sagrada inemiphumela yokulahla isisu futhi ingasiza ekunciphiseni ukuqunjelwa kwabanye abantu.

Kungenzeka kungasebenzi ku ...

• Ukukhipha ikholoni ngaphambi kwe-colonoscopy. Ucwaningo oluningi lukhombisa ukuthi ukuthatha i-cascara sagradaalong ne-magnesium sulfate noma ubisi lwe-magnesia akukuthuthukisi ukuhlanzwa kwamathumbu kubantu abenza i-colonoscopy.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Ukuphazamiseka okuthinta ukugeleza kwe-bile esibindini njengama-gallstones.
• Isifo sesibindi.
• Umdlavuza.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-cascara sagrada yalokhu kusetshenziswa.

ICascara sagrada iqukethe amakhemikhali ashukumisa amathumbu futhi abe nethonya le-laxative.

Lapho ithathwa ngomlomo: ICascara sagrada iyi OKUNGENZEKA UKUPHEPHA kubantu abaningi abadala lapho bethathwe isikhathi esingaphansi kwesonto elilodwa. Imiphumela emibi ibandakanya ukungakhululeki esiswini kanye namajaqamba.

ICascara sagrada MHLAWUMBI ANGIPHEPHILE lapho isetshenziselwa isikhathi esingaphezu kwesonto elilodwa. Lokhu kungadala imiphumela emibi kakhulu ebandakanya ukwehla emzimbeni; amazinga aphansi e-potassium, i-sodium, i-chloride, namanye ama- "electrolyte" egazini; izinkinga zenhliziyo; ubuthakathaka bemisipha; nabanye.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi ngabe i-cascara sagrada iphephile yini ukuthi ingasetshenziswa uma ukhulelwe. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa. ICascara sagrada MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngenkathi uncelisa ibele. ICascara sagrada ingawela obisini lwebele futhi ingadala isifo sohudo enganeni esencelisayo.

Izingane: ICascara sagrada iyi MHLAWUMBI ANGIPHEPHILE ezinganeni lapho zithathwa ngomlomo. Unganiki i-cascara sagrada ezinganeni. Banamathuba amaningi okuthi kunabantu abadala baphelelwe amanzi emzimbeni futhi balimale nokulahleka kwama-electrolyte, ikakhulukazi i-potassium.

Ukuphazamiseka kwamathumbu (GI) njengokuvinjelwa kwamathumbu, isifo seCrohn, i-ulcerative colitis, i-appendicitis, izilonda zesisu, noma ubuhlungu besisu obungachazeki.: Abantu abananoma iyiphi yale mibandela akufanele basebenzise i-cascara sagrada.

Maphakathi

Qaphela ngale nhlanganisela.

I-Digoxin (Lanoxin)

ICascara sagrada wuhlobo lwe-laxative okuthiwa i-laxative evuselelayo. Ama-laxatives ashukumisayo anganciphisa amazinga e-potassium emzimbeni. Izinga eliphansi le-potassium lingakhuphula ubungozi bemiphumela emibi ye-digoxin (Lanoxin).

Imithi yokuvuvukala (iCorticosteroids)

Eminye imithi yokuvuvukala inganciphisa i-potassium emzimbeni. ICascara sagrada wuhlobo lwe-laxative olunganciphisa ne-potassium emzimbeni. Ukuthatha i-cascara sagrada kanye neminye imithi yokuvuvukala kunganciphisa i-potassium emzimbeni kakhulu.

Eminye imishanguzo yokuvuvukala ifaka i-dexamethasone (i-Decadron), i-hydrocortisone (i-Cortef), i-methylprednisolone (i-Medrol), i-prednisone (i-Deltasone), neminye.

Ama-laxatives ashukumisayo

ICascara sagrada wuhlobo lwe-laxative okuthiwa i-laxative evuselelayo. Ama-laxatives ashukumisayo asheshisa amathumbu. Ukuthatha i-cascara sagrada kanye namanye ama-laxatives avuselelayo kungasheshisa amathumbu kakhulu futhi kubangele ukomisa namaminerali aphansi emzimbeni.

Amanye ama-laxatives ashukumisayo afaka i-bisacodyl (Correctol, Dulcolax), uwoyela we-castor (iPurge), i-senna (iSenokot), namanye.

I-Warfarin (Coumadin)

ICascara sagrada ingasebenza njenge-laxative. Kwabanye abantu i-cascara sagrada ingadala isifo sohudo. Uhudo lungakhuphula imiphumela ye-warfarin futhi lwenyuse nengozi yokopha. Uma uthatha i-warfarin, ungathathi amanani amaningi wecascara.

Amaphilisi wamanzi (Imithi yokwelapha)

ICascara sagrada iyi-laxative. Amanye ama-laxatives anganciphisa i-potassium emzimbeni. "Amaphilisi amanzi" nawo anganciphisa i-potassium emzimbeni. Ukuthatha i-cascara sagrada kanye "namaphilisi amanzi" kunganciphisa i-potassium emzimbeni kakhulu.

Amanye "amaphilisi amanzi" anganciphisa i-potassium afaka i-chlorothiazide (Diuril), chlorthalidone (Thalitone), furosemide (Lasix), hydrochlorothiazide (HCTZ, HydroDiuril, Microzide), namanye.

Amakhambi aqukethe i-Chromium nezithasiselo

ICascara sagrada iqukethe i-chromium futhi ingakhuphula ubungozi be-chromium poisoning lapho ithathwa ngama-chromium supplements noma amakhambi aqukethe i-chromium afana ne-bilberry, imvubelo ye-brewer, noma i-horsetail.

Amakhambi aqukethe ama-glycosides enhliziyo

Ama-glycosides enhliziyo angamakhemikhali afana nomuthi kadokotela ongu-digoxin. Ama-glycosides enhliziyo angadala ukuthi umzimba ulahlekelwe yi-potassium.

ICascara sagrada nayo ingadala ukuthi umzimba ulahlekelwe yi-potassium ngoba yi-laxative evuselelayo. Ama-laxatives ashukumisayo asheshisa amathumbu. Ngenxa yalokho, ukudla kungahlali emathunjini isikhathi eside ngokwanele ukuze umzimba umunce amaminerali afana ne-potassium. Lokhu kungaholela emazingeni aphansi we-potassium afanele.

Ukusebenzisa i-cascara sagrada kanye nomuthi onama-glycosides enhliziyo kungadala ukuthi umzimba ulahlekelwe yi-potassium eningi, futhi lokhu kungadala ukulimala kwenhliziyo. Amakhambi aqukethe i-glycosides yenhliziyo afaka i-hellebore emnyama, izimpande ze-hemp zaseCanada, i-digitalis leaf, i-hedge mustard, i-figwort, umnduze wezimpande zesigodi, i-motherwort, iqabunga le-oleander, isitshalo semehlo se-pheasant, impande ye-pleurisy, isikali seqabunga le-bulb le-squill, inkanyezi yaseBhetlehema, imbewu ye-strophanthus , no uzara. Gwema ukusebenzisa i-cascara sagrada nganoma iyiphi yalezi.

Ezehhashi

IHorsetail inyusa ukukhiqizwa komchamo (kusebenza njenge-diuretic) futhi lokhu kungadala ukuthi umzimba ulahlekelwe yi-potassium.

ICascara sagrada nayo ingadala ukuthi umzimba ulahlekelwe yi-potassium ngoba yi-laxative evuselelayo. Ama-laxatives ashukumisayo asheshisa amathumbu. Ngenxa yalokho, ukudla kungahlali emathunjini isikhathi eside ngokwanele ukuze umzimba umunce amaminerali afana ne-potassium. Lokhu kungaholela emazingeni aphansi we-potassium afanele.

Uma amazinga e-potassium ehla kakhulu, inhliziyo ingalimala. Kukhona ukukhathazeka ukuthi ukusebenzisa i-horsetail ne-cascara sagrada kwandisa ingozi yokulahlekelwa yi-potassium eningi futhi kwandisa ingozi yokulimala kwenhliziyo. Gwema ukusebenzisa i-cascara sagrada nge-horsetail.

Ilayisensi

I-Licorice ibangela ukuthi umzimba ulahlekelwe yi-potassium.

ICascara sagrada nayo ingadala ukuthi umzimba ulahlekelwe yi-potassium ngoba yi-laxative evuselelayo. Ama-laxatives ashukumisayo asheshisa amathumbu. Ngenxa yalokho, ukudla kungahlali emathunjini isikhathi eside ngokwanele ukuze umzimba umunce amaminerali afana ne-potassium. Lokhu kungaholela emazingeni aphansi we-potassium afanele.

Uma amazinga e-potassium ehla kakhulu, inhliziyo ingalimala. Kukhona ukukhathazeka ukuthi ukusebenzisa i-licorice ne-cascara sagrada kwandisa ingozi yokulahlekelwa yi-potassium eningi futhi kwandisa ingozi yokulimala kwenhliziyo. Gwema ukusebenzisa i-cascara sagrada ne-licorice.

Amakhambi we-laxative ashukumisayo

ICascara sagrada iyi-laxative evuselelayo. Ama-laxatives ashukumisayo asheshisa amathumbu. Ngenxa yalokho, ukudla kungahlali emathunjini isikhathi eside ngokwanele ukuze umzimba umunce amaminerali afana ne-potassium. Lokhu kungaholela emazingeni aphansi we-potassium afanele.

Kukhona ukukhathazeka ngokuthi ukuthatha i-cascara sagrada kanye namanye amakhambi avuselelayo angenza amazinga e-potassium ehle kakhulu, futhi lokhu kungalimaza inhliziyo. Amanye amakhambi ashukumisayo e-laxative yi-aloe, i-alder buckthorn, impande emnyama, ifulegi eliluhlaza okwesibhakabhaka, i-butternut bark, i-colocynth, i-buckthorn yase-Europe, i-fo ti, i-gamboge, i-gossypol, i-bindweed enkulu, i-jalap, imana, impande ye-scammony yaseMexico, i-rhubarb, i-senna kanye ne-dock ephuzi. Gwema ukusebenzisa i-cascara sagrada nganoma iyiphi yalezi.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele we-cascara sagrada uncike ezintweni eziningana ezifana nobudala bomsebenzisi, impilo, nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi lokunquma uhla olufanele lwamanani we-cascara sagrada. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa. Aulne Noir, Bitter Bark, Bois Noir, Bois à Poudre, Borzène, Bourgène, Buckthorn, California Buckthorn, Cáscara, Cascara Sagrada, Chittem Bark, Dogwood Bark, Écorce Sacrée, Frangula purshiana, Nerprun, Pastel Bourexhi, Purshi , Rhamnus purshiana, Rhubarbe des Paysans, Bark Engcwele, Sagrada Bark, Yellow Bark.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UCirillo C, uCapasso R. Ukuqunjelwa kanye nemithi yezitshalo: ukubuka konke. I-Phytother Res 2015; 29: 1488-93. Buka okungaqondakali.
2. I-Nakasone ES, iTokeshi J. Ukutholwa okuxakile: icala le-cholangiocarcinoma elikhonjwe ngengozi ngemuva kokulimala kanzima kwesibindi ngenxa yokungenisa kwe-cascara sagrada. IHawaii J Med Impilo Yomphakathi 2015; 74: 200-2. Buka okungaqondakali.
3. Chang, L. C., Sheu, H. M., Huang, Y. S., Tsai, T. R., no Kuo, K. W. Umsebenzi wenoveli we-emodin: ukuthuthukiswa kokulungiswa kwe-nucleotide ukukhishwa kwe-UV- kanye ne-cisplatin-eyenziwe ngomonakalo we-DNA kumaseli womuntu. I-Biochem Pharmacol 1999; 58: 49-57.
4. Chang, C. J., Ashendel, C. L., Geahlen, R. L., McLaughlin, J. L., and Waters, D. J. Oncogene signal transduction inhibitors ezivela ezitshalweni zokwelapha. KuVivo 1996; 10: 185-190.
5. U-Chen, H. C., Hsieh, W. T., Chang, W. C., no-Chung, J. G. Aloe-emodin benze in vitro G2 / M ukuboshwa komjikelezo weseli kumaseli we-promyelocytic leukemia HL-60 cells. Ukudla Chem Toxicol 2004; 42: 1251-1257.
6. UPetticrew, M., Watt, I., noSheldon, T. Ukubuyekezwa okuhlelekile kokusebenza kwama-laxatives kubantu asebekhulile. Ukuhlolwa kwe-Health Technol. 1997; 1: i-52. Buka okungaqondakali.
7. UTramonte, S. M., Brand, M. B., Mulrow, C. D., Amato, M. G., O'Keefe, M. E., noRamirez, G. Ukwelashwa kokuqunjelwa okungapheli kubantu abadala. Ukubuyekezwa okuhlelekile. J Gen. Intern. I-Med 1997; 12: 15-24. Buka okungaqondakali.
8. UMereto, E., Ghia, M., noBrambilla, G. Ukuhlolwa komsebenzi ongaba khona we-carcinogenic weSenna noCascara glycosides wekoloni yamagundane. Umdlavuza Lett 3-19-1996; 101: 79-83. Buka okungaqondakali.
9. USilberstein, E. B., Fernandez-Ulloa, M., noHolo, J. Ingabe ama-cathartics omlomo ayigugu ekwandiseni ukuskena kwe-gallium? Ukuxhumana okuphelele. J Nucl. Medied 1981; 22: 424-427. Buka okungaqondakali.
10. UMarchesi, M., Marcato, M., noSilvestrini, C. [Isipiliyoni somtholampilo ngokulungiselela okuqukethe i-cascara sagrada ne-boldo ekwelapheni ukuqunjelwa okulula kwabadala]. I-G.Clin.Med. 1982; 63 (11-12): 850-863. Buka okungaqondakali.
11. Imfoloko, F.T., Ekberg, O., Nilsson, G., Rerup, C., noSkinhoj, A. Izindlela zokuhlanza i-Colon. Ucwaningo lomtholampilo ezigulini eziyi-1200. I-gastrointest.I-radiol. 1982; 7: 383-389. Buka okungaqondakali.
12. UNovetsky, G. J., Turner, D. A., Ali, A., Raynor, W. J., Jr., noFordham, E. W. Ukuhlanza ikholoni ku-gallium-67 scintigraphy: ukuqagela okulindelekile kwemigomo. I-AJR Am J Roentgenol. 1981; 137: 979-981. Buka okungaqondakali.
13. I-Stern, i-F.H. Ukuqokwa - uphawu olukuyo yonke indawo: umphumela wokulungiselela oqukethe ukugxila kwe-prune ne-cascarin. UJ Am Geriatr Soc 1966; 14: 1153-1155. Buka okungaqondakali.
14. U-Hangartner, P. J., Munch, R., Meier, J., Ammann, R., noBuhler, H. Ukuqhathaniswa kwezindlela ezintathu zokuhlanza ikoloni: ukuhlolwa kwesilingo somtholampilo esingahleliwe neziguli ezingama-300 ezihamba ngezinyawo. I-Endoscopy 1989; 21: 272-275. Buka okungaqondakali.
15. UPhillip, J., Schubert, G. E., Thiel, A., noWolters, U.[Ukulungiselela i-colonoscopy usebenzisa i-Golytely - indlela eqinisekile? Ukuqhathanisa isifundo se-histological ne-clinical phakathi kokuhlanjululwa kanye ne-saline laxatives]. IMed Klin (Munich) 7-15-1990; 85: 415-420. Buka okungaqondakali.
16. UBorkje, B., Pedersen, R., Lund, G. M., Enehaug, J. S., noBerstad, A. Ukusebenza nokwamukelwa kwezinqubo ezintathu zokuhlanza amathumbu. UScand J Gastroenterol 1991; 26: 162-166. Buka okungaqondakali.
17. U-Huang, Q., Shen, H. M., no-Ong, C. N. Umphumela wokuvimbela we-emodin ekuhlaselweni kwe-tumor ngokucindezela i-activator protein-1 ne-nuclear factor-kappaB. I-Biochem Pharmacol 7-15-2004; 68: 361-371. Buka okungaqondakali.
18. U-Liu, J. B., Gao, X. G., Lian, T., Zhao, A. Z., no-Li, K. Z. [I-Apoptosis yamaseli we-hepatoma HepG2 womuntu abangelwa yi-emodin in vitro]. Ai.Zheng. 2003; 22: 1280-1283. Buka okungaqondakali.
19. I-Lai, GH, Zhang, Z., ne-Sirica, i-AE Celecoxib isebenza ngendlela ezimele ye-cyclooxygenase-2 kanye nokusebenzisana ne-emodin ukucindezela i-rat cholangiocarcinoma ukukhula kwe-vitro ngokusebenzisa indlela ebandakanya ukwenziwa ngcono kwe-Akt nokwandiswa kokusebenza kwamakhasethi-9 futhi -3. UMol. Umdlavuza Ther 2003; 2: 265-271. Buka okungaqondakali.
20. Chen, YC, Shen, SC, Lee, WR, Hsu, FL, Lin, HY, Ko, CH, noTseng, SW Emodin induces apoptosis in human promyeloleukemic HL-60 amaseli ahambisana nokusebenza kwe-caspase 3 cascade kepha ezimele nge-oxygen esebenzayo ukukhiqizwa kwezinhlobo. I-Biochem Pharmacol 12-15-2002; 64: 1713-1724. Buka okungaqondakali.
21. Kuo, P. L., Lin, T. C., noLin, C. C. Umsebenzi we-antiproliferative we-aloe-emodin uhamba nge-p53-ethembeke futhi i-p21-ethembeke endleleni ye-apoptotic emigqeni yeseli ye-hepatoma. Impilo Sci 9-6-2002; 71: 1879-1892. Buka okungaqondakali.
22. URosengren, J. E. no-Aberg, T. Ukuhlanzwa kwekholoni ngaphandle kwama-enemas. Imisebe 1975; 15: 421-426. Buka okungaqondakali.
23. UKoyama, J., Morita, I., Tagahara, K., Nobukuni, Y., Mukainaka, T., Kuchide, M., Tokuda, H., noNishino, H. Chemopreventive imiphumela ye-emodin ne-cassiamin B esikhunjeni segundane. carcinogenesis. I-Cancer Lett 8-28-2002; 182: 135-139. Buka okungaqondakali.
24. U-Lee, H. Z., Hsu, S. L., Liu, M. C., noWu, C. H. Imiphumela nezinqubo ze-aloe-emodin ekufeni kweseli ku-lung lung squamous cell carcinoma. I-Eur J Pharmacol 11-23-2001; 431: 287-295. Buka okungaqondakali.
25. U-Lee, H. Z. Amaphrotheni kinase C abandakanyeka ku-aloe-emodin- kanye ne-emodin eyenziwe nge-apoptosis kuseli lesifo samaphaphu. UBr J Pharmacol 2001; 134: 1093-1103. Buka okungaqondakali.
26. Lee, H. Z. Imiphumela nezinqubo ze-emodin ekufeni kweseli kumaphaphu womuntu squamous cell carcinoma. UBr J Pharmacol 2001; 134: 11-20. Buka okungaqondakali.
27. UMuller, S. O., Eckert, I., Lutz, W. K., noStopper, H. Genotoxicity wezinto ezisetshenziswayo zomuthi we-laxative emodin, i-aloe-emodin ne-danthron kumaseli wezilwane ezincelisayo: i-topoisomerase II iyalamula? UMutat.Izimali 12-20-1996; 371 (3-4): 165-173. Buka okungaqondakali.
28. ICascara sagrada, ama-aloe laxatives, izindlela zokuvimbela inzalo ze-O-9 zingezigaba II-FDA. Ishidi Le-Tan ngoMeyi 13, 2002.
29. Ukukhethwa kwama-laxatives wokuqunjelwa. Incwadi ka-Pharmacist's Letter / Prescriber's 2002; 18: 180614.
30. Ukuphathwa Kwezokudla Nezidakamizwa, i-HHS. Isimo sezithako ezithize ezengeziwe ezingekho ekhawunteni zomuthi II no-III. Umthetho wokugcina. Ukubhaliswa Kwezezimali 2002; 67: 31125-7. Buka okungaqondakali.
31. UNadir A, uReddy D, uVan Thiel DH. ICascara-sagrada yenze i-intrahepatic cholestasis ibangela umfutho wegazi ophezulu we-portal: umbiko wecala nokubuyekezwa kwe-herbal hepatotoxicity. NginguJ J Gastroenterol 2000; 95: 3634-7. Buka okungaqondakali.
32. UNusko G, uSchneider B, uSchneider I, et al. Ukusetshenziswa kwe-anthranoid laxative akuyona ingozi ebangelwa i-colorectal neoplasia: imiphumela yocwaningo lokulawulwa kwamacala okulindelekile. Isisu 2000; 46: 651-5. Buka okungaqondakali.
33. I-DS encane. Imiphumela Yezidakamizwa Ekuvivinyweni Kwelabhoratri Yomtholampilo 4th ed. IWashington: I-AACC Press, 1995.
34. UCovington TR, et al. Incwajana Yezidakamizwa Ezingabhalisiwe. Umhla ka-11. IWashington, DC: I-American Pharmaceutical Association, 1996.
35. Ukuphikiswa kukaBrinker F. Herb nokusebenzisana kwezidakamizwa. Okwesibili. USandy, NOMA: I-Eclectic Medical Publications, 1998.
36. UGruenwald J, Brendler T, Jaenicke C. PDR weMithi Yemithi. 1st ed. IMontvale, NJ: I-Medical Economics Company, Inc., ngo-1998.
37. Wichtl MW. Izidakamizwa ze-Herbal kanye ne-Phytopharmaceuticals. Umhleli. UNM Bisset. Stuttgart: IMedpharm GmbH Scientific Publishers, 1994.
38. Ukubuyekezwa Kwemikhiqizo Yemvelo ngamaqiniso nokuqhathanisa. ISt. Louis, MO: IWolters Kluwer Co., 1999.
39. INewall CA, Anderson LA, uPhilpson JD. Herbal Medicine: Umhlahlandlela Wongoti Bezempilo. ILondon, e-UK: I-Pharmaceutical Press, ngo-1996.
40. UTyler VE. Amakhambi Okuzikhethela. IBinghamton, NY: Imikhiqizo Yemikhiqizo Yezokwelapha, 1994.
41. UBlumenthal M, u-ed. I-Complete German Commission E Monographs: Umhlahlandlela Wezokwelapha Emithini Yemithi. I-Trans. S. Klein. IBoston, MA: Umkhandlu Wezamabhodlela waseMelika, ngo-1998.
42. Ama-monographs ngokusetshenziswa kokwelashwa kwemithi yezitshalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.

Kugcine ukubuyekezwa - 09/09/2020